---
title: "Axon stock resurgence faces Q2 earnings test"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295006980.md"
description: "The Taser maker is working on a fifth straight year of 30%+ sales growth."
datetime: "2026-08-05T20:07:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295006980.md)
  - [en](https://longbridge.com/en/news/295006980.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295006980.md)
---

# Axon stock resurgence faces Q2 earnings test

The Taser maker is working on a fifth straight year of 30%+ sales growth.

### Related Stocks

- [AXON.US](https://longbridge.com/en/quote/AXON.US.md)
- [AXUP.US](https://longbridge.com/en/quote/AXUP.US.md)

## Related News & Research

- [Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth](https://longbridge.com/en/news/295303253.md)
- [Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?](https://longbridge.com/en/news/295066256.md)
- [Axon Q2 revenue beats estimates, outlook raised](https://longbridge.com/en/news/295007974.md)
- [What to expect from LB Foster’s (FSTR) Q2 earnings](https://longbridge.com/en/news/295313092.md)
- [Axon Enterprise, Inc (NASDAQ:AXON) Given Average Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/291695708.md)